Amgen (AMGN) Tops Q2 EPS by 69c, Beats on Revenue; Offers FY26 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq hits record high as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $402.24 -0.2%
Revenue Growth %: +5.1%
Financial Fact:
Product sales: 5.52B
Today's EPS Names:
VFS, PKE, More
Revenue Growth %: +5.1%
Financial Fact:
Product sales: 5.52B
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $6.29, $0.69 better than the analyst estimate of $5.60. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.43 billion.
GUIDANCE:
Amgen sees FY2026 EPS of $22.30-$23.50, versus the consensus of $22.35. Amgen sees FY2026 revenue of $38.2-39.4 billion, versus the consensus of $37.7 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs sees AI investment adding to European growth in 2026
- CRH plc (CRH) call put ratio 4.4 calls 1 put with a focus on 2K contracts of November 95 calls
- Five9 (FIVN) call put ratio 1 call 6.8 puts with a focus on 3500 contracts of January 32.50 puts
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
